Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-01-17Clinical Trial Update: Ottawa Sunglasses at Night for Mania Study [NA]
A completed clinical trial from the Ottawa Hospital Research Institute evaluated sunglasses-at-night light therapy for mania-related sleep d…
-
FDA approval · 2025-01-16FDA Approved: HALOPERIDOL LACTATE — Supplemental Application (Mylan Institutional LLC)
FDA granted a supplemental approval for HALOPERIDOL LACTATE to Mylan Institutional LLC, issuing a supplemental application for this generic …
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs [Phase 4]
Phase 4 trial assessing metformin for overweight/obese children and adolescents with bipolar disorder treated with second-generation antipsy…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Bipolar Transcranial Alternating Current Stimulation (tACS) [NA]
A completed clinical trial evaluating bipolar disorder treatment with transcranial alternating current stimulation (tACS) has posted results…
-
CLINICAL_TRIALS trial_result · 2025-01-14Clinical Trial Update: Lifestyle Intervention for Young Adults With Serious Mental Illness [NA]
Completed results posted for a lifestyle intervention trial in young adults with serious mental illness, including schizophrenia, schizoaffe…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-01-14FDA Approved: CARBAMAZEPINE — Original Application (Ascend Laboratories, LLC)
FDA approved a generic carbamazepine product from Ascend Laboratories, LLC under an Original Application (ANDA).
-
FDA approval · 2025-01-13FDA Approved: HALOPERIDOL — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for HALOPERIDOL LACTATE, a generic injectable form of haloperidol from Fresenius Kabi USA, LLC.
-
FDA approval · 2025-01-13FDA Approved: ARIPIPRAZOLE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA supplemental approval for ARIPIPRAZOLE by Amneal Pharmaceuticals LLC under an ANDA (ANDA 203906). This document records the supplemental…
-
FDA approval · 2025-01-13FDA Approved: ARIPIPRAZOLE — Supplemental Application (VistaPharm, LLC)
FDA approved a supplemental application for aripiprazole by VistaPharm, LLC (ANDA 212870). The authorization pertains to changes to the appr…
-
FDA approval · 2025-01-13FDA Approved: CARBAMAZEPINE — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's original application for a generic carbamazepine product.
-
CLINICAL_TRIALS research · 2025-01-09Clinical Trial Update: BioClock: Bright Light Therapy for Depressive Disorders [NA]
The document reports a University of Leiden-sponsored clinical trial evaluating BioClock bright light therapy for major depressive disorder …
-
FDA approval · 2025-01-08FDA Approved: LAMOTRIGINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for lamotrigine from Zydus Pharmaceuticals USA Inc. under an ANDA, indicating an approved change…
-
CLINICAL_TRIALS research · 2025-01-07Clinical Trial Update: Low-Intensity Focused Ultrasound of the Amygdala for Bipolar Disorder [EARLY_Phase 1]
An early-phase Phase 1 trial at Massachusetts General Hospital is evaluating low-intensity focused ultrasound of the amygdala for bipolar di…
-
CLINICAL_TRIALS research · 2024-12-27Clinical Trial Update: Effect of Blue Light Blocking on Reducing Manic Symptoms in Bipolar Disorder [NA]
This trial investigates whether blue light blocking can reduce manic symptoms in bipolar disorder; recruitment has not yet begun.
-
FDA approval · 2024-12-26FDA Approved: LAMOTRIGINE — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved a supplemental application for lamotrigine by Amneal Pharmaceuticals LLC (ANDA 207497).
-
CLINICAL_TRIALS research · 2024-12-24Clinical Trial Update: The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects [Phase 2]
Phase 2 clinical trial investigating how blocking AMPA receptors modulates ketamine's anti-suicidal effects; currently recruiting.
-
CLINICAL_TRIALS research · 2024-12-20Clinical Trial Update: Validation and Impact of Cardiorespiratory Fitness in Severe Mental Illness - the Heart in Mind Project
The Heart in Mind Project is validating how cardiorespiratory fitness relates to health outcomes in people with severe mental illness, inclu…
-
EMA approval · 2024-12-18EMA Authorised: Zyprexa Velotab (olanzapine) — CHEPLAPHARM Registration GmbH
The EMA authorised Zyprexa Velotab, a generic olanzapine product, under CHEPLAPHARM Registration GmbH for schizophrenia and bipolar disorder…
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Clinical Validation Study for EDIT-B Test: an Aid for Differential Diagnosis of Bipolar Disorder, Based on RNA Editing Blood Biomarkers
Completed clinical validation study for the EDIT-B blood biomarker test designed to differentiate bipolar disorder from major depressive dis…
-
CLINICAL_TRIALS trial_result · 2024-12-17Clinical Trial Update: Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar or Schizophrenia Illness [NA]
A completed clinical trial assessed the effects of a ketogenic diet on metabolic and psychiatric health in adults with bipolar disorder or s…
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: The Bipolar Lithium Imaging Scan Study.
This clinical trial update indicates that the lithium imaging scan study for bipolar disorder I or II is currently recruiting at Leiden Univ…
-
CLINICAL_TRIALS research · 2024-12-12Clinical Trial Update: Development and Application of Precision Treatment Strategies for Common Mental Disorders [NA]
This clinical trial update from Peking University describes the development and application of precision treatment strategies for common men…
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: Delivering Telemetry-Triggered Educational Content Using MyChart in Mood Disorders [NA]
A completed clinical trial evaluated telemetry-triggered educational content delivered via the MyChart patient portal for mood disorders, in…
-
FDA approval · 2024-12-10FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Original Application (Fresenius Kabi USA, LLC)
The FDA approved an original application for chlorpromazine hydrochloride from Fresenius Kabi USA, LLC, making this generic antipsychotic av…
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: Characterizing MyMood Patterns of Use
A Sunnybrook Health Sciences Centre clinical trial is characterizing patterns of MyMood use in individuals with mood-related disorders; the …